

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 7.89196474 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 7.45395379 |
| 3 | protein neddylation (GO:0045116) | 6.94277635 |
| 4 | blood coagulation, intrinsic pathway (GO:0007597) | 6.31051672 |
| 5 | regulation of platelet aggregation (GO:0090330) | 6.02135256 |
| 6 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.61683307 |
| 7 | regulation of platelet activation (GO:0010543) | 5.52104360 |
| 8 | platelet aggregation (GO:0070527) | 5.48404902 |
| 9 | adenosine receptor signaling pathway (GO:0001973) | 5.46529862 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.31423544 |
| 11 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.28358299 |
| 12 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.89477382 |
| 13 | negative regulation of norepinephrine secretion (GO:0010700) | 4.80393569 |
| 14 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.79689844 |
| 15 | neutrophil activation (GO:0042119) | 4.76726676 |
| 16 | positive regulation of mast cell activation (GO:0033005) | 4.75821752 |
| 17 | lipoxygenase pathway (GO:0019372) | 4.60112423 |
| 18 | negative regulation of platelet activation (GO:0010544) | 4.51335937 |
| 19 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.47633983 |
| 20 | angiogenesis involved in wound healing (GO:0060055) | 4.43398601 |
| 21 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.38315165 |
| 22 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.34609228 |
| 23 | negative regulation of heart rate (GO:0010459) | 4.31790568 |
| 24 | low-density lipoprotein particle remodeling (GO:0034374) | 4.17998282 |
| 25 | granulocyte activation (GO:0036230) | 4.17502821 |
| 26 | platelet degranulation (GO:0002576) | 4.14102680 |
| 27 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.01910181 |
| 28 | megakaryocyte development (GO:0035855) | 4.01645918 |
| 29 | polyamine biosynthetic process (GO:0006596) | 3.96679669 |
| 30 | platelet formation (GO:0030220) | 3.91833304 |
| 31 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.91390501 |
| 32 | regulation of lipoprotein metabolic process (GO:0050746) | 3.88696829 |
| 33 | homotypic cell-cell adhesion (GO:0034109) | 3.87568096 |
| 34 | platelet activation (GO:0030168) | 3.80723788 |
| 35 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.80719753 |
| 36 | regulation of integrin activation (GO:0033623) | 3.80242896 |
| 37 | positive regulation of macrophage differentiation (GO:0045651) | 3.77438536 |
| 38 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.75881392 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60872861 |
| 40 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.57747280 |
| 41 | negative regulation of T cell apoptotic process (GO:0070233) | 3.55845128 |
| 42 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.53531903 |
| 43 | positive regulation of receptor recycling (GO:0001921) | 3.53327405 |
| 44 | autophagic vacuole fusion (GO:0000046) | 3.52255813 |
| 45 | purinergic receptor signaling pathway (GO:0035587) | 3.50435294 |
| 46 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.45134755 |
| 47 | negative regulation of protein localization to cell surface (GO:2000009) | 3.43093865 |
| 48 | leukocyte degranulation (GO:0043299) | 3.42746085 |
| 49 | positive regulation of hemostasis (GO:1900048) | 3.39999576 |
| 50 | positive regulation of blood coagulation (GO:0030194) | 3.39999576 |
| 51 | negative regulation of response to food (GO:0032096) | 3.38915268 |
| 52 | negative regulation of appetite (GO:0032099) | 3.38915268 |
| 53 | beta-amyloid metabolic process (GO:0050435) | 3.38614580 |
| 54 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.36093344 |
| 55 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.34658306 |
| 56 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.33465627 |
| 57 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.31895492 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 3.31040369 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.30348595 |
| 60 | mitochondrial calcium ion transport (GO:0006851) | 3.28264615 |
| 61 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.28208990 |
| 62 | termination of signal transduction (GO:0023021) | 3.27460943 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.26783579 |
| 64 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.25190044 |
| 65 | vesicle targeting (GO:0006903) | 3.24650309 |
| 66 | regulation of norepinephrine secretion (GO:0014061) | 3.23153544 |
| 67 | negative regulation of heart contraction (GO:0045822) | 3.19964326 |
| 68 | regulation of endothelial cell differentiation (GO:0045601) | 3.18947033 |
| 69 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.18304467 |
| 70 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16624308 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16468159 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16232032 |
| 73 | phospholipid homeostasis (GO:0055091) | 3.14229864 |
| 74 | negative regulation of stress fiber assembly (GO:0051497) | 3.10990667 |
| 75 | reverse cholesterol transport (GO:0043691) | 3.07353433 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05119229 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.05119229 |
| 78 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.04418369 |
| 79 | extracellular fibril organization (GO:0043206) | 3.03433328 |
| 80 | positive regulation of coagulation (GO:0050820) | 3.03252987 |
| 81 | regulation of cholesterol efflux (GO:0010874) | 3.03110243 |
| 82 | phagocytosis, engulfment (GO:0006911) | 2.93291905 |
| 83 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.92527652 |
| 84 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.91005899 |
| 85 | negative regulation of catecholamine secretion (GO:0033604) | 2.89615141 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.89550064 |
| 87 | regulation of thymocyte apoptotic process (GO:0070243) | 2.88270667 |
| 88 | cyclooxygenase pathway (GO:0019371) | 2.87868351 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.87358598 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.87358598 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86557530 |
| 92 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.86346346 |
| 93 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.85036738 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84417331 |
| 95 | regulation of receptor recycling (GO:0001919) | 2.82752126 |
| 96 | regulation of hemostasis (GO:1900046) | 2.79246889 |
| 97 | regulation of blood coagulation (GO:0030193) | 2.79246889 |
| 98 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.77731751 |
| 99 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.74729481 |
| 100 | negative regulation of cell junction assembly (GO:1901889) | 2.74697055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 5.00050774 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.85566782 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.47543002 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.85531494 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.72933353 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 3.63515872 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.28950453 |
| 8 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 3.12031656 |
| 9 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.96279867 |
| 10 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.94279940 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 2.88782380 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74447203 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71853618 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.70107655 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69244164 |
| 16 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.63396981 |
| 17 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.59715807 |
| 18 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.51690575 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.40023788 |
| 20 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34278455 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32683587 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.31178423 |
| 23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.30962439 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14430104 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10075964 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95478141 |
| 27 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.94977647 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89882740 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88882504 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87614537 |
| 31 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.68313342 |
| 32 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.66714973 |
| 33 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.65474822 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63693256 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58284517 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53655232 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49842721 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48153087 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47463122 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45759886 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42465051 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40704024 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39967345 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39895325 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37382619 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35998534 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34527945 |
| 48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.34380595 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34042244 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32955783 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28220013 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27523718 |
| 53 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.25065266 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23164059 |
| 55 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.20934502 |
| 56 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.18444209 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16181215 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09663877 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.06221021 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05556356 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05400592 |
| 62 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04909436 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00992096 |
| 64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00071730 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99475219 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95340398 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94985028 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94003646 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93120346 |
| 70 | MAF_26560356_Chip-Seq_TH1_Human | 0.92751311 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91242358 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90078759 |
| 73 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89766858 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89632772 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88893814 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88893814 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 0.88285525 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88022095 |
| 79 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87772401 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85833138 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85817663 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84542080 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84378444 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83667011 |
| 85 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79859590 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.78569051 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77996461 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.76298007 |
| 89 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.76107757 |
| 90 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75665437 |
| 91 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75368435 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75243354 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.74975022 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74954813 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74228824 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74087273 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.73857575 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73088317 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71581811 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71348883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 9.90215670 |
| 2 | MP0008004_abnormal_stomach_pH | 5.30579340 |
| 3 | MP0003724_increased_susceptibility_to | 3.86805122 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.62715569 |
| 5 | MP0004510_myositis | 2.91366914 |
| 6 | MP0005083_abnormal_biliary_tract | 2.63332973 |
| 7 | MP0003303_peritoneal_inflammation | 2.44518710 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.29112735 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.21117316 |
| 10 | MP0000343_altered_response_to | 2.14133982 |
| 11 | MP0005058_abnormal_lysosome_morphology | 1.97347397 |
| 12 | MP0004084_abnormal_cardiac_muscle | 1.88638513 |
| 13 | MP0000230_abnormal_systemic_arterial | 1.80466936 |
| 14 | MP0002132_abnormal_respiratory_system | 1.79083694 |
| 15 | MP0003638_abnormal_response/metabolism_ | 1.77824258 |
| 16 | MP0010155_abnormal_intestine_physiology | 1.76543221 |
| 17 | MP0002736_abnormal_nociception_after | 1.74687232 |
| 18 | MP0001851_eye_inflammation | 1.74294585 |
| 19 | MP0005671_abnormal_response_to | 1.73489039 |
| 20 | MP0003436_decreased_susceptibility_to | 1.71359299 |
| 21 | MP0003828_pulmonary_edema | 1.69454700 |
| 22 | MP0002398_abnormal_bone_marrow | 1.68217120 |
| 23 | MP0003879_abnormal_hair_cell | 1.66842244 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.66686934 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.66510848 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.66211181 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.66211181 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.63295379 |
| 29 | MP0004947_skin_inflammation | 1.51935666 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.51828694 |
| 31 | MP0005410_abnormal_fertilization | 1.51804081 |
| 32 | MP0008872_abnormal_physiological_respon | 1.46826393 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.45261977 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.42758554 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.41310134 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.40283493 |
| 37 | MP0002723_abnormal_immune_serum | 1.37541809 |
| 38 | MP0003866_abnormal_defecation | 1.31363518 |
| 39 | MP0001663_abnormal_digestive_system | 1.31271575 |
| 40 | MP0001800_abnormal_humoral_immune | 1.27998713 |
| 41 | MP0001879_abnormal_lymphatic_vessel | 1.27939468 |
| 42 | MP0000858_altered_metastatic_potential | 1.27798200 |
| 43 | MP0000249_abnormal_blood_vessel | 1.22943035 |
| 44 | MP0009763_increased_sensitivity_to | 1.22491086 |
| 45 | MP0002419_abnormal_innate_immunity | 1.22204662 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.21867926 |
| 47 | MP0004130_abnormal_muscle_cell | 1.21724979 |
| 48 | MP0002429_abnormal_blood_cell | 1.21682222 |
| 49 | MP0009764_decreased_sensitivity_to | 1.21370566 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.20532600 |
| 51 | MP0002722_abnormal_immune_system | 1.19860561 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.19270124 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.17820809 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.17421515 |
| 55 | MP0001819_abnormal_immune_cell | 1.16313548 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.13011748 |
| 57 | MP0005387_immune_system_phenotype | 1.11339050 |
| 58 | MP0001790_abnormal_immune_system | 1.11339050 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.11052344 |
| 60 | MP0000685_abnormal_immune_system | 1.10734756 |
| 61 | MP0005025_abnormal_response_to | 1.08548542 |
| 62 | MP0000716_abnormal_immune_system | 1.05357735 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.01956083 |
| 64 | MP0009697_abnormal_copulation | 1.01317173 |
| 65 | MP0005646_abnormal_pituitary_gland | 1.00481595 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.98713507 |
| 67 | MP0008874_decreased_physiological_sensi | 0.96627479 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.92623015 |
| 69 | MP0000490_abnormal_crypts_of | 0.88080415 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 0.86179803 |
| 71 | MP0000703_abnormal_thymus_morphology | 0.84833135 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.83124251 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.81680727 |
| 74 | MP0004883_abnormal_blood_vessel | 0.81107461 |
| 75 | MP0009278_abnormal_bone_marrow | 0.80744063 |
| 76 | MP0008260_abnormal_autophagy | 0.79580304 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.79165391 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.78720789 |
| 79 | MP0003075_altered_response_to | 0.78036065 |
| 80 | MP0005165_increased_susceptibility_to | 0.78003376 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.77244181 |
| 82 | MP0001970_abnormal_pain_threshold | 0.75603757 |
| 83 | MP0005385_cardiovascular_system_phenoty | 0.75338556 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 0.75338556 |
| 85 | MP0002735_abnormal_chemical_nociception | 0.74473579 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.72985113 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.72186468 |
| 88 | MP0005535_abnormal_body_temperature | 0.71688105 |
| 89 | MP0005023_abnormal_wound_healing | 0.71681165 |
| 90 | MP0000358_abnormal_cell_content/ | 0.71220425 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.70870386 |
| 92 | MP0002972_abnormal_cardiac_muscle | 0.67590440 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.67013046 |
| 94 | MP0004484_altered_response_of | 0.66142089 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.65091786 |
| 96 | MP0002405_respiratory_system_inflammati | 0.64958865 |
| 97 | MP0001664_abnormal_digestion | 0.64906745 |
| 98 | MP0002128_abnormal_blood_circulation | 0.64007128 |
| 99 | MP0005501_abnormal_skin_physiology | 0.63393503 |
| 100 | MP0009785_altered_susceptibility_to | 0.61007485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.72116355 |
| 2 | Purpura (HP:0000979) | 9.25799101 |
| 3 | Epistaxis (HP:0000421) | 7.83340184 |
| 4 | Gingival bleeding (HP:0000225) | 6.50989180 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 5.83132132 |
| 6 | Impaired platelet aggregation (HP:0003540) | 5.56828679 |
| 7 | Abnormal platelet function (HP:0011869) | 5.56828679 |
| 8 | Acanthocytosis (HP:0001927) | 4.35673276 |
| 9 | Spontaneous hematomas (HP:0007420) | 4.34019417 |
| 10 | Poikilocytosis (HP:0004447) | 4.28092670 |
| 11 | Dyschromatopsia (HP:0007641) | 3.86193318 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.59683502 |
| 13 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.57734878 |
| 14 | Conjunctival telangiectasia (HP:0000524) | 3.39965949 |
| 15 | Bruising susceptibility (HP:0000978) | 3.29515214 |
| 16 | Abnormal pupillary function (HP:0007686) | 3.24371349 |
| 17 | Abnormality of lateral ventricle (HP:0030047) | 3.22482718 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.08655678 |
| 19 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.97469600 |
| 20 | Increased density of long bones (HP:0006392) | 2.86030681 |
| 21 | Paralysis (HP:0003470) | 2.80551995 |
| 22 | Hyperthyroidism (HP:0000836) | 2.73828706 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65971277 |
| 24 | Obstructive lung disease (HP:0006536) | 2.65971277 |
| 25 | Hepatosplenomegaly (HP:0001433) | 2.57246103 |
| 26 | Polycythemia (HP:0001901) | 2.55084515 |
| 27 | Xanthomatosis (HP:0000991) | 2.53912023 |
| 28 | Stomatitis (HP:0010280) | 2.50916551 |
| 29 | Increased IgM level (HP:0003496) | 2.47595850 |
| 30 | Ventricular fibrillation (HP:0001663) | 2.38957599 |
| 31 | Joint swelling (HP:0001386) | 2.33698793 |
| 32 | Joint hemorrhage (HP:0005261) | 2.31264956 |
| 33 | Abnormality of iron homeostasis (HP:0011031) | 2.27814665 |
| 34 | Upper limb muscle weakness (HP:0003484) | 2.27115349 |
| 35 | Encephalitis (HP:0002383) | 2.26352439 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26017781 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.15832463 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.12435493 |
| 39 | Tinnitus (HP:0000360) | 2.11688364 |
| 40 | Nausea (HP:0002018) | 2.11179285 |
| 41 | Male infertility (HP:0003251) | 2.10999468 |
| 42 | Episodic fever (HP:0001954) | 2.09222466 |
| 43 | Decreased central vision (HP:0007663) | 2.08670933 |
| 44 | Abnormal auditory evoked potentials (HP:0006958) | 2.08446411 |
| 45 | Spontaneous abortion (HP:0005268) | 2.04285674 |
| 46 | Prolonged bleeding time (HP:0003010) | 12.0036430 |
| 47 | Menorrhagia (HP:0000132) | 11.0121463 |
| 48 | Increased mean platelet volume (HP:0011877) | 10.8218891 |
| 49 | Abnormal platelet volume (HP:0011876) | 10.3220378 |
| 50 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98535645 |
| 51 | Dysautonomia (HP:0002459) | 1.98192718 |
| 52 | Increased serum ferritin (HP:0003281) | 1.98038558 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 1.87527621 |
| 54 | Arterial thrombosis (HP:0004420) | 1.84205671 |
| 55 | 3-Methylglutaconic aciduria (HP:0003535) | 1.81506592 |
| 56 | Papillary thyroid carcinoma (HP:0002895) | 1.73847378 |
| 57 | Myocardial infarction (HP:0001658) | 1.70761195 |
| 58 | Truncus arteriosus (HP:0001660) | 1.70442719 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 1.69128911 |
| 60 | Recurrent abscess formation (HP:0002722) | 1.68034761 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.62965067 |
| 62 | Diplopia (HP:0000651) | 1.59543501 |
| 63 | Abnormality of binocular vision (HP:0011514) | 1.59543501 |
| 64 | Abnormal hemoglobin (HP:0011902) | 1.58980533 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 1.58732402 |
| 66 | Cholecystitis (HP:0001082) | 1.57988192 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 1.57988192 |
| 68 | Granulocytopenia (HP:0001913) | 1.56364625 |
| 69 | Inflammation of the large intestine (HP:0002037) | 1.54345151 |
| 70 | Abnormal ciliary motility (HP:0012262) | 1.54049206 |
| 71 | Vertigo (HP:0002321) | 1.52906087 |
| 72 | Thrombophlebitis (HP:0004418) | 1.50807234 |
| 73 | Abnormality of the prostate (HP:0008775) | 1.46037548 |
| 74 | Chest pain (HP:0100749) | 1.45339431 |
| 75 | Muscle fibrillation (HP:0010546) | 1.42872010 |
| 76 | Testicular neoplasm (HP:0010788) | 1.42247193 |
| 77 | Leukocytosis (HP:0001974) | 1.41896385 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 1.41385857 |
| 79 | Hypertriglyceridemia (HP:0002155) | 1.40415500 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 1.39747946 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.39221996 |
| 82 | Abnormality of alanine metabolism (HP:0010916) | 1.39221996 |
| 83 | Hyperalaninemia (HP:0003348) | 1.39221996 |
| 84 | Thyroid-stimulating hormone excess (HP:0002925) | 1.38689487 |
| 85 | Abnormal large intestine physiology (HP:0012700) | 1.38532387 |
| 86 | Microcytic anemia (HP:0001935) | 1.37591321 |
| 87 | Hypophosphatemic rickets (HP:0004912) | 1.37446250 |
| 88 | Ileus (HP:0002595) | 1.37254866 |
| 89 | Tongue fasciculations (HP:0001308) | 1.36803089 |
| 90 | Arthropathy (HP:0003040) | 1.36153881 |
| 91 | Dysostosis multiplex (HP:0000943) | 1.34570877 |
| 92 | Leiomyosarcoma (HP:0100243) | 1.34277532 |
| 93 | Uterine leiomyosarcoma (HP:0002891) | 1.34277532 |
| 94 | Biliary tract neoplasm (HP:0100574) | 1.33971520 |
| 95 | Thrombocytosis (HP:0001894) | 1.33755775 |
| 96 | Chronic otitis media (HP:0000389) | 1.31158250 |
| 97 | Mucosal telangiectasiae (HP:0100579) | 1.31011250 |
| 98 | Basal ganglia calcification (HP:0002135) | 1.30881444 |
| 99 | Cerebral ischemia (HP:0002637) | 1.30859532 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.30269676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.54718192 |
| 2 | MST4 | 4.55051281 |
| 3 | BMX | 4.33420224 |
| 4 | EIF2AK1 | 3.94273938 |
| 5 | MYLK | 3.45642803 |
| 6 | TEC | 3.00984703 |
| 7 | BTK | 2.99329657 |
| 8 | PTK2B | 2.51021987 |
| 9 | SYK | 2.29727460 |
| 10 | BMPR2 | 2.20025585 |
| 11 | GRK6 | 2.14203125 |
| 12 | ZAP70 | 2.06189652 |
| 13 | CSF1R | 1.93692238 |
| 14 | ILK | 1.87292816 |
| 15 | GRK5 | 1.86794528 |
| 16 | FGR | 1.78441650 |
| 17 | PIK3CG | 1.75790910 |
| 18 | TAOK3 | 1.71471637 |
| 19 | BLK | 1.69499885 |
| 20 | MAP2K3 | 1.62501629 |
| 21 | HCK | 1.56818355 |
| 22 | STK3 | 1.45558542 |
| 23 | TNK2 | 1.37446194 |
| 24 | STK24 | 1.36210279 |
| 25 | FES | 1.32681728 |
| 26 | ADRBK2 | 1.31014584 |
| 27 | MAPKAPK3 | 1.24943986 |
| 28 | PAK1 | 1.21498927 |
| 29 | LYN | 1.20730091 |
| 30 | MATK | 1.20304955 |
| 31 | TAOK2 | 1.11252266 |
| 32 | IKBKB | 1.02334353 |
| 33 | DAPK3 | 1.01326778 |
| 34 | CSK | 0.99287696 |
| 35 | TAOK1 | 0.98337726 |
| 36 | SIK3 | 0.97666189 |
| 37 | PIM2 | 0.95333727 |
| 38 | MAP3K5 | 0.95142431 |
| 39 | RET | 0.89961188 |
| 40 | LMTK2 | 0.88410627 |
| 41 | MARK3 | 0.88049756 |
| 42 | TESK2 | 0.86906731 |
| 43 | ITK | 0.86294289 |
| 44 | PDK1 | 0.82560458 |
| 45 | IRAK1 | 0.82285358 |
| 46 | TNIK | 0.81318550 |
| 47 | ACVR1B | 0.80566906 |
| 48 | MAP3K3 | 0.80289311 |
| 49 | EPHA3 | 0.78355796 |
| 50 | PLK2 | 0.78174175 |
| 51 | MAP4K1 | 0.77709113 |
| 52 | MAP3K11 | 0.76787923 |
| 53 | DAPK2 | 0.72912884 |
| 54 | MAPK12 | 0.72676081 |
| 55 | PDPK1 | 0.72554668 |
| 56 | JAK2 | 0.68590336 |
| 57 | ADRBK1 | 0.68532285 |
| 58 | TXK | 0.68456209 |
| 59 | JAK3 | 0.66170682 |
| 60 | ERBB2 | 0.62485520 |
| 61 | PRKD1 | 0.61433602 |
| 62 | ARAF | 0.61048731 |
| 63 | PNCK | 0.60498406 |
| 64 | MAP3K1 | 0.56858424 |
| 65 | YES1 | 0.55638531 |
| 66 | EPHB1 | 0.55464534 |
| 67 | MAP2K1 | 0.55090925 |
| 68 | IRAK4 | 0.54644319 |
| 69 | PRKACG | 0.53027221 |
| 70 | LCK | 0.52337243 |
| 71 | RAF1 | 0.51898167 |
| 72 | PKN1 | 0.51897365 |
| 73 | KSR2 | 0.50896591 |
| 74 | FYN | 0.45911178 |
| 75 | TLK1 | 0.44277055 |
| 76 | FER | 0.44037639 |
| 77 | GRK1 | 0.42960858 |
| 78 | STK4 | 0.42933639 |
| 79 | MAP3K2 | 0.40426716 |
| 80 | PDGFRB | 0.40353297 |
| 81 | DAPK1 | 0.37153628 |
| 82 | PKN2 | 0.36506005 |
| 83 | CDK8 | 0.36117682 |
| 84 | MAPK13 | 0.34831759 |
| 85 | PIM1 | 0.32916354 |
| 86 | EPHB2 | 0.32783984 |
| 87 | MINK1 | 0.30954064 |
| 88 | PRKCD | 0.30527263 |
| 89 | PRKG1 | 0.30336632 |
| 90 | PRKCB | 0.30177088 |
| 91 | DYRK1B | 0.29501570 |
| 92 | JAK1 | 0.29475019 |
| 93 | TRIM28 | 0.29412055 |
| 94 | IRAK3 | 0.28790072 |
| 95 | DYRK3 | 0.26892959 |
| 96 | IRAK2 | 0.26606170 |
| 97 | MAPK11 | 0.26574137 |
| 98 | PRKCQ | 0.24679058 |
| 99 | SRC | 0.21758249 |
| 100 | CDK14 | 0.20806802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.82757507 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.63824939 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.05191037 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.90606495 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.64847733 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.27093320 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.06470177 |
| 8 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.02514390 |
| 9 | Gap junction_Homo sapiens_hsa04540 | 1.78416470 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.67222176 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61018427 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.59412248 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.57789871 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56496984 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51119846 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.49140629 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44377594 |
| 18 | Endocytosis_Homo sapiens_hsa04144 | 1.41973473 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36718306 |
| 20 | Alcoholism_Homo sapiens_hsa05034 | 1.27743166 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27309510 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22541642 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20215760 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16021864 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15503542 |
| 26 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12998172 |
| 27 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.12741224 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.11074740 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10641728 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10020031 |
| 31 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08247252 |
| 32 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06877537 |
| 33 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05501033 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01754541 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.00211891 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99818621 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 0.97634014 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 0.92036303 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91249193 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89354036 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88065145 |
| 42 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85259621 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85108641 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84993559 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 0.84925490 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84759994 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83625305 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82889889 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82243508 |
| 50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78834991 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 0.77123907 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75171547 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74479218 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73309815 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71106419 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70267996 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67482656 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.66878296 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63322137 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62487840 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61812235 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59487291 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59038705 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58002861 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56535991 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56408427 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55595759 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55058021 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.53214831 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52797835 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.52701887 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51589391 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51516636 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.49175787 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49065665 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48916602 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48752478 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48470571 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47637374 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.47184126 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46857326 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.45827199 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44885844 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44674537 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43365901 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.42651453 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42623465 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41220725 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40750276 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39221641 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38784082 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37422165 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37203222 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36844640 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36728778 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36371978 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34451431 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34011087 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.32485419 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32110584 |

